Recent Updates — NKLR

On September 17, 2026, directors Rex Jackson and Michael Howard resigned from the board of Terra Innovatum Global N.V. Peter Hastings also resigned to transition into a consulting role supporting commercialization efforts. On September 22, 2026, Tony Tullio, Michael Modro, and Kostadin Ivanov were appointed as new independent directors, with Mr. Tullio serving as interim chairman of the Audit Committee. Terra Innovatum Global N.V. operates in the biotechnology industry, focusing on the development of innovative therapeutic solutions.

Terra Innovatum Global N.V. appointed Katherine Williams as Chief Financial Officer of its US subsidiary and an executive director of the parent company, effective August 21, 2026. Her employment agreement includes a $465,000 annual base salary, a $40,000 signing bonus, and performance-based bonuses ranging from 50% to 250% of base salary. She also receives EUR 200,000 annually for her directorship role. The agreements extend until the close of the 2028 annual general meeting. This company operates in the global innovation and technology sector.

Terra Innovatum Global N.V. announced that its Board of Directors appointed Joanna Lohkamp as an interim non-executive director, effective July 1, 2026. Ms. Lohkamp will also serve as a member of the Audit Committee and as the chair of the Remuneration Committee until the next annual general meeting. The company is a Netherlands-based entity listed on the Nasdaq.